What Do the US Midterms Mean for Medtech?

Key retirements, important changes in leadership, and some surprising  new faces. Now that the dust has almost settled, leaving just one Senate  run-off and several House seats still to be settled, what does the  election’s outcome mean for the medical device industry, both in terms  of prospects for the rest of this year and for the new Congress in 2023?  MDMA’s Mark Leahey and Advamed’s Greg Crist offer their perspectives on  this podcast with Market Pathways editors Stephen Levin and David  Filmore.